Current Clinical Trials on Vitiligo / Switra in Ayurveda / Venpadai in Siddha
Current Clinical Trials on Vitiligo (Switra in Ayurveda, Venpadai in Siddha)
- HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
- Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
- Vitiligo Skin Transplantation
- Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
- Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
- Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
- Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
- Clinical Trial of Simvastatin to Treat Generalized Vitiligo
- Botulinum Toxin Treatment for Localized Vitiligo
- Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
- Punchgrafting Techniques for Vitiligo
- Efficacy and Safety of ACH24 in the Treatment of Vitiligo
- Treatment of Vitiligo With Low-energy Visible Light Laser
- Narrowband UVB Treatment in Patients With Vitiligo
- Topical Bimatoprost Solution 0.03%in Stable Vitiligo
- Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
- Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
- Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
- Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
- Questionnaire and Laboratory Data on Vitiligo Vulgaris
- Emervel Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
- Safety Study of Cosmetic Tissue Augmentation in People of Color
- Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
- Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
- A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
- Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
- Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI
0 comments:
Post a Comment